Search
for
Sort by
Research 811–840 of 1000+
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data
- Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study
- Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Oclacitinib Treatment and Surgical Management in a Case of Periocular Eosinophilic Furunculosis and Vasculitis with Secondary Eyelid Fusion in a Diabetic Cat
- Differential cold stress intensities drive unique morphological and transcriptomic changes in Zea mays root hairs
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- IL-15 Prolongs Anagen, Stimulates Proliferation, and Suppresses Apoptosis in the Hair Matrix of Human Scalp Hair Follicles
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Clinicopathologic features, demographics, disease burden, and therapeutics in alopecic sarcoidosis: a case series and systematic review
- Vitiligo
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Molecular Mechanisms of Hair Follicle Development
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity